Literature DB >> 28271589

Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria.

M Loredana Marcovecchio1, Päivi H Tossavainen2, Katharine Owen3, Catherine Fullah1, Paul Benitez-Aguirre4, Stefano Masi5, Ken Ong6, Helen Nguyen5, Scott T Chiesa5, R Neil Dalton7, John Deanfield5, David B Dunger1.   

Abstract

OBJECTIVE: To evaluate the association between a clustering of cardio-metabolic risk factors in parents and the development of microalbuminuria (MA) in their offspring with childhood-onset type 1 diabetes (T1D).
METHODS: The study population comprised 53 parents (mean age [±SD]: 56.7±6.2 years) of 35 T1D young people with MA (MA+) and 86 parents (age: 56.1±6.3 years) of 50 matched offspring with normoalbuminuria (MA-), who underwent clinical, biochemical and cardiovascular imaging assessments. The primary study endpoint was the difference between parents from the MA+ and MA- groups in a cardio-metabolic risk score, calculated as the average value of the standardized measures (z-scores) for waist circumference, blood pressure, fasting glucose, insulin, HDL-cholesterol and triglycerides levels. Cardiovascular parameters, including carotid intima-media thickness (cIMT), flow-mediated dilatation (FMD) and pulse wave velocity (PWV), were also assessed. A DXA scan was performed to assess body composition.
RESULTS: The cardio-metabolic risk score was significantly higher in parents of MA+ compared to parents of MA- offspring (mean [95% CI]: 1.066[0.076; 2.056] vs -0.268[-0.997; 0.460], P = .03). Parents of MA+ offspring had slightly higher values of waist circumference, lipids, insulin and blood pressure, although only diastolic blood pressure was statistically different between the 2 groups (P = .0085). FMD, cIMT, PWV (all P > .3), and DXA parameters (all P > .2) were not significantly different between the 2 groups.
CONCLUSIONS: Parents of young offspring with childhood-onset T1D and MA showed an abnormal metabolic profile, reflected by a calculated risk score. The finding supports the role of a familial predisposition to risk of developing diabetic nephropathy.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardio-metabolic; microalbuminuria; parents; type 1 diabetes

Mesh:

Year:  2017        PMID: 28271589      PMCID: PMC6186416          DOI: 10.1111/pedi.12515

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  30 in total

Review 1.  Status and rationale of renoprotection studies in adolescents with type 1 diabetes.

Authors:  M Loredana Marcovecchio; Päivi H Tossavainen; David B Dunger
Journal:  Pediatr Diabetes       Date:  2009-06-02       Impact factor: 4.866

2.  Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.

Authors:  J A Fagerudd; L Tarnow; P Jacobsen; S Stenman; F S Nielsen; K J Pettersson-Fernholm; C Grönhagen-Riska; H H Parving; P H Groop
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

3.  Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children.

Authors:  Nina E Berentzen; Alet H Wijga; Lenie van Rossem; Gerard H Koppelman; Bo van Nieuwenhuizen; Ulrike Gehring; Annemieke M W Spijkerman; Henriëtte A Smit
Journal:  Diabetologia       Date:  2016-05-30       Impact factor: 10.122

4.  Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.

Authors:  Samy Hadjadj; Franck Péan; Yves Gallois; Philippe Passa; Robert Aubert; Laurent Weekers; Vincent Rigalleau; Bernard Bauduceau; Amine Bekherraz; Ronan Roussel; Bernard Dussol; Michel Rodier; Richard Marechaud; Pierre J Lefebvre; Michel Marre
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

5.  Physical activity energy expenditure predicts progression toward the metabolic syndrome independently of aerobic fitness in middle-aged healthy Caucasians: the Medical Research Council Ely Study.

Authors:  Ulf Ekelund; Søren Brage; Paul W Franks; Susie Hennings; Sue Emms; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

6.  Paternal phenotype is associated with microalbuminuria in young adults with Type 1 diabetes mellitus of short duration.

Authors:  C J Schultz; R N Dalton; M Selwood; D B Dunger; H A W Neil
Journal:  Diabet Med       Date:  2004-03       Impact factor: 4.359

7.  Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study).

Authors:  Lars Bo Andersen; Maarike Harro; Luis B Sardinha; Karsten Froberg; Ulf Ekelund; Søren Brage; Sigmund Alfred Anderssen
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

8.  Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Josef Coresh; Yingying Sang; John Chalmers; Caroline Fox; Eliseo Guallar; Tazeen Jafar; Simerjot K Jassal; Gijs W D Landman; Paul Muntner; Paul Roderick; Toshimi Sairenchi; Ben Schöttker; Anoop Shankar; Michael Shlipak; Marcello Tonelli; Jonathan Townend; Arjan van Zuilen; Kazumasa Yamagishi; Kentaro Yamashita; Ron Gansevoort; Mark Sarnak; David G Warnock; Mark Woodward; Johan Ärnlöv
Journal:  Lancet Diabetes Endocrinol       Date:  2015-05-28       Impact factor: 32.069

9.  Effect of parental type 2 diabetes on offspring with type 1 diabetes.

Authors:  Lena M Thorn; Carol Forsblom; Johan Wadén; Jenny Söderlund; Milla Rosengård-Bärlund; Markku Saraheimo; Outi Heikkilä; Kustaa Hietala; Kim Pettersson-Fernholm; Jorma Ilonen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

10.  An independent effect of parental lipids on the offspring lipid levels in a cohort of adolescents with type 1 diabetes.

Authors:  M Loredana Marcovecchio; Paivi H Tossavainen; James Jn Heywood; R Neil Dalton; David B Dunger
Journal:  Pediatr Diabetes       Date:  2012-02-27       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.